View all trials
Showing 65 results

The table can be sorted by “Study title” or “Protocol ID” sorted alphabetically in either Ascending (default) or Descending (on second click) order.
The default sorting is by “Study title” in alphabetical ascending order.

Study titleProtocol IDDisease type(s)Location(s)Eligibility criteriaStatus
 Page 1 of 7, items 1 to 10 of 65.
A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens AOST06B1
Solid tumours
Osteosarcoma
Lady Cilento Children's HospitalBrisbane
Princess Margaret HospitalPerth
Women and Children's HospitalAdelaide
Open
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors ABTR01B1
Solid tumours
Rare
Lady Cilento Children's HospitalBrisbane
Princess Margaret HospitalPerth
Women and Children's HospitalAdelaide
Open
A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens AALL05B1
Leukaemia
Leukaemia
Other Leukaemia
Princess Margaret HospitalPerth
Open
A Clinical and Molecular Risk-Directed Therapy For Newly Diagnosed Medulloblastoma SJMB12
Brain and Spinal Tumours
Medulloblastoma/PNET
Children's Hospital at WestmeadSydney
Lady Cilento Children's HospitalBrisbane
Princess Margaret HospitalPerth
Royal Children's Hospital Melbourne
Starship Children's HospitalAuckland, NZ
Sydney Children's Hospital
Open
A COG Study for Collecting and Banking Ewing Sarcoma Specimens AEWS07B1
Solid tumours
Ewings sarcoma
Lady Cilento Children's HospitalBrisbane
Princess Margaret HospitalPerth
Women and Children's HospitalAdelaide
Open
A multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial. CCtl019B2206
Royal Children's Hospital Melbourne
Open
A Phase 1 Study of Intravenous EGFR-ErbituxEDVSMIT (EEDVSMit) in Children with Recurrent / Refractory Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor (EGFR). ECREST
Sydney Children's Hospital
Open
A Phase 1 study of Temozolomide, Irinotecan, and O6BG for Children with Recurrent or Resistant Neuroblastoma. TIO
Solid tumours
Neuroblastoma
Children's Hospital at WestmeadSydney
Open
A Phase 1/2 Study of Valproate in Combination withInterferon alpha in Relapsed, Recurrent or Progressive Neuroblastoma ACCT003
Solid tumours
Neuroblastoma
Children's Hospital at WestmeadSydney
John Hunter Children's HospitalNewcastle
Lady Cilento Children's HospitalBrisbane
Princess Margaret HospitalPerth
Sydney Children's Hospital
Women and Children's HospitalAdelaide
Open
A Phase I Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects with Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma EZH102
Solid tumours
Children's Hospital at WestmeadSydney
Lady Cilento Children's HospitalBrisbane
Royal Children's Hospital Melbourne
Sydney Children's Hospital
Open